Articles

• Select this article
  • M Dowsett

  Editorial

  Endocr Relat Cancer 2 (1) 1, doi:10.1677/erc.0.0020001
  • Extract
  • Full Text (PDF)
• Select this article
  • M Dowsett,
  • S R D Johnston,
  • J Newby,
  • M Golding,
  • N Sacks,
  • and IE Smith

  Mechanisms of hormone response: a role for apoptosis

  Endocr Relat Cancer 2 (1) 3-11, doi:10.1677/erc.0.0020003
  • Extract
  • Full Text (PDF)
• Select this article
  • D W Rea and
  • M G Parker

  Structure and function of the oestrogen receptor in relation to its altered sensitivity to oestradiol and tamoxifen

  Endocr Relat Cancer 2 (1) 13-17, doi:10.1677/erc.0.0020013
  • Extract
  • Full Text (PDF)
• Select this article
  • S A W Fuqua,
  • C Wiltschke,
  • C Castles,
  • D Wolf,
  • and D C Allred

  A role for estrogen-receptor variants in endocrine resistance

  Endocr Relat Cancer 2 (1) 19-25, doi:10.1677/erc.0.0020019
  • Abstract
  • Full Text (PDF)
• Select this article
  • N Brünner,
  • M D Johnson,
  • C Holst-Hansen,
  • J F Kiilgaard,
  • E W Thompson,
  • and R Clarke

  Acquisition of estrogen independence and antiestrogen resistance in breast cancer: association with the invasive and metastatic phenotype

  Endocr Relat Cancer 2 (1) 27-35, doi:10.1677/erc.0.0020027
  • Extract
  • Full Text (PDF)
• Select this article
  • B R Westley and
  • F E B May

  In vitro development of tamoxifen resistance

  Endocr Relat Cancer 2 (1) 37-44, doi:10.1677/erc.0.0020037
  • Extract
  • Full Text (PDF)
• Select this article
  • V C Jordan,
  • W L Catherino,
  • and D M Wolf

  Drug resistance to tamoxifen: mutant estrogen receptors as a potential mechanism of tamoxifen-stimulated tumor growth

  Endocr Relat Cancer 2 (1) 45-51, doi:10.1677/erc.0.0020045
  • Extract
  • Full Text (PDF)
• Select this article
  • C K Osborne

  Tamoxifen metabolism as a mechanism for resistance

  Endocr Relat Cancer 2 (1) 53-58, doi:10.1677/erc.0.0020053
  • Extract
  • Full Text (PDF)
• Select this article
  • R Clarke and
  • N Brünner

  Cross-resistance and molecular mechanisms in antiestrogen resistance

  Endocr Relat Cancer 2 (1) 59-72, doi:10.1677/erc.0.0020059
  • Abstract
  • Full Text (PDF)
• Select this article
  • W R Miller,
  • R A Hawkins,
  • P Mullen,
  • P Sourdaine,
  • and J Telford

  Aromatase inhibition: determinants of response and resistance

  Endocr Relat Cancer 2 (1) 73-85, doi:10.1677/erc.0.0020073
  • Extract
  • Full Text (PDF)
• Select this article
  • R L Sutherland,
  • C K W Watts,
  • and E A Musgrove

  Cell cycle control by steroid hormones in breast cancer: implications for endocrine resistance

  Endocr Relat Cancer 2 (1) 87-96, doi:10.1677/erc.0.0020087
  • Extract
  • Full Text (PDF)
• Select this article
  • V M Macaulay,
  • S B Fox,
  • H Zhang,
  • R M Whitehouse,
  • R D Leek,
  • K C Gatter,
  • R Bicknell,
  • and A L Harris

  Breast cancer angiogenesis and tamoxifen resistance

  Endocr Relat Cancer 2 (1) 97-103, doi:10.1677/erc.0.0020097
  • Extract
  • Full Text (PDF)
• Select this article
  • S R D Johnston,
  • G Saccani-Jotti,
  • I E Smith,
  • J Newby,
  • and M Dowsett

  Change in oestrogen receptor expression and function in tamoxifen-resistant breast cancer

  Endocr Relat Cancer 2 (1) 105-110, doi:10.1677/erc.0.0020105
  • Abstract
  • Full Text (PDF)
• Select this article
  • E Levin,
  • S Caruso,
  • and A M Actis

  Functional expression of estrogen receptors in experimental and human mammary tumors

  Endocr Relat Cancer 2 (1) 111-113, doi:10.1677/erc.0.0020111
  • Extract
  • Full Text (PDF)
• Select this article
  • R I Nicholson,
  • J M W Gee,
  • A B Francis,
  • D L Manning,
  • A E Wakeling,
  • and B S Katzenellenbogen

  Observations arising from the use of pure antioestrogens on oestrogen-responsive (MCF-7) and oestrogen growth-independent (K3) human breast cancer cells

  Endocr Relat Cancer 2 (1) 115-121, doi:10.1677/erc.0.0020115
  • Extract
  • Full Text (PDF)
• Select this article
  • L C J Dorssers,
  • T van Agthoven,
  • and A Brinkman

  Involvement of genetic alterations in breast tumour progression to hormone independence in vitro

  Endocr Relat Cancer 2 (1) 123-126, doi:10.1677/erc.0.0020123
  • Abstract
  • Full Text (PDF)
• Select this article
  • P E Lønning,
  • SI Helle,
  • V J Frost,
  • J M P Holly,
  • and K Hall

  Alterations in plasma IGF-I caused by hormone manipulation; of relevance to the mechanism of action and acquired resistance to endocrine treatment in breast cancer?

  Endocr Relat Cancer 2 (1) 127-130, doi:10.1677/erc.0.0020127
  • Abstract
  • Full Text (PDF)